WILKES-BARRE GENERAL HOSPITAL — History
CCN 390137 | 3-year financial timeline | COVID resilience: 19/100
🛡️ Public data only — no PHI permitted on this instance.
$262M
Latest Revenue (FY2022)
-3.3%
Revenue CAGR (3yr)
-13.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $280M | $268M | $262M | -2.3% | -3.3% |
| Operating Expenses | $284M | $291M | $296M | +1.8% | +2.0% |
| Operating Margin | -1.4% | -8.3% | -13.0% | -55.3% | +0.0% |
| Net Income | $-4M | $-22M | $-34M | -51.7% | +0.0% |
| Licensed Beds | 220 | 199 | 188 | -5.5% | -7.6% |
| Total Patient Days | 48,148 | 44,448 | 37,941 | -14.6% | -11.2% |
| Medicare Day % | 48% | 43% | 42% | -2.2% | -6.1% |
| Medicaid Day % | 3% | 3% | 3% | +5.5% | -7.2% |
COVID Impact & Recovery
Resilience Score: 19/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -6.5% ($280M → $262M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-3.3%
This Hospital
+7.6%
State Avg
Latest Margin
-13.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $253M | -18.8% |
| FY2024 (proj) | $244M | -24.6% |
| FY2025 (proj) | $235M | -30.4% |